OAKRIDGE INTERNATIONAL
Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It… Read more
OAKRIDGE INTERNATIONAL (U9O0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, OAKRIDGE INTERNATIONAL (U9O0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OAKRIDGE INTERNATIONAL - Net Assets Trend (None–None)
This chart illustrates how OAKRIDGE INTERNATIONAL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OAKRIDGE INTERNATIONAL (None–None)
The table below shows the annual net assets of OAKRIDGE INTERNATIONAL from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OAKRIDGE INTERNATIONAL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OAKRIDGE INTERNATIONAL Competitors by Market Cap
The table below lists competitors of OAKRIDGE INTERNATIONAL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
1ST QUANTUM MINLS
BE:IZ1
|
$209.38K |
|
SVHG
STU:SVHG
|
$209.66K |
|
GEOLOGICA RESOURCE CORP.
F:862
|
$209.73K |
|
Mandeville Ventures Inc.
V:MAND-P
|
$209.73K |
|
New Era Helium Inc Warrants
NASDAQ:NEHCW
|
$209.34K |
|
DBA Sempra 5.750% Junior Subordinated Notes due 2079
NYSE:SREA
|
$209.29K |
|
JERONIMO MARTINS
MU:JEM
|
$209.22K |
|
Danske InvSelectGlSuFut3 DKK d
CO:DSIGSFUT3DKKD
|
$209.21K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OAKRIDGE INTERNATIONAL's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OAKRIDGE INTERNATIONAL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OAKRIDGE INTERNATIONAL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OAKRIDGE INTERNATIONAL's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OAKRIDGE INTERNATIONAL (U9O0) | €- | N/A | N/A | $209.37K |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |